Current status of viral expression systems in plants and perspectives for oral vaccines development

Plant Molecular Biology

Volumn 87, Issue 3, 2015, Pages 203-217

  Salazar González, Jorge A ^a   Bañuelos Hernández, Bernardo ^a   Rosales Mendoza, Sergio ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

Agrobacterium DNA delivery; Chimeric virus; Oral vaccine; Viral replicon; Virus like particles

Indexed keywords

RECOMBINANT VACCINE; VIRUS LIKE PARTICLE VACCINE; VIRUS VACCINE;

ANIMAL; BIOSYNTHESIS; BIOTECHNOLOGY; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; ORAL DRUG ADMINISTRATION; PLANT VIRUS; TRANSGENIC PLANT; VIRUS;

ADMINISTRATION, ORAL; ANIMALS; BIOTECHNOLOGY; GENETIC VECTORS; HUMANS; PLANT VIRUSES; PLANTS, GENETICALLY MODIFIED; VACCINES, SYNTHETIC; VACCINES, VIRUS-LIKE PARTICLE; VIRAL VACCINES; VIRUSES;

EID: 84925511517     PISSN: 01674412     EISSN: 15735028     Source Type: Journal    
DOI: 10.1007/s11103-014-0279-5     Document Type: Review

References (118)

1. Angell SM, Baulcombe DC (1997) Consistent gene silencing in transgenic plants expressing a replicating Potato virus X RNA. EMBO J 16:3675–3684
2. Argüello-Astorga GR, Guevara-Gonzalez RG, Herrera-Estrella LR, Rivera-Bustamante RF (1994) Geminivirus replication origins have a group-specific organization of iterative elements: a model for replication. Virology 203(1):90–100
3. Azegami T, Yuki Y, Kiyono H (2014) Challenges in mucosal vaccines for the control of infectious diseases. Int Immunol 26:517–528
4. Azmi F, Ahmad Fuaad AA, Skwarczynski M, Toth I (2013) Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother 10:27332
5. Baulcombe D (2004) RNA silencing in plants. Nature 7006:356–363
6. Baulcombe D, Chapman S, Santa Cruz S (1995) Jellyfish green fluorescent protein as a reporter for virus infections. Plant J 7(6):1045–1053
7. Cañizares MC, Lomonossoff GP, Nicholson L (2005) Development of Cowpea mosaic virus-based vectors for the production of vaccines in plants. Expert Rev Vaccines 4:687–697
8. Casal JI, Langeveld JP, Cortés E, Schaaper WW, van Dijk E, Vela C, Kamstrup S, Meloen RH (1995) Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence. J Virol 69(11):7274–7277
9. Čeřovská N, Hoffmeisterová H, Pecenková T, Moravec T, Synková H, Plchová H, Velemínský J (2008) Transient expression of HPV16 E7 peptide (aa 44–60) and HPV16 L2 peptide (aa 108–120) on chimeric potyvirus-like particles using Potato virus X-based vector. Protein Expr Purif 58(1):154–161
10. Čeřovská N, Hoffmeisterova H, Moravec T, Plchova H, Folwarczna J, Synkova H, Ryslava H, Ludvikova V, Smahel M (2012) Transient expression of human papillomavirus type 16 L2 epitope fused to N- and C-terminus of coat protein of Potato virus X in plants. J Biosci 37(1):125–133
11. Chung HY, Lee HH, Kim KI, Chung HY, Hwang-Bo J, Park JH Sunter G, Kim JB, Shon DH, Kim W, Chung IS (2011) Expression of a recombinant chimeric protein of hepatitis A virus VP1-Fc using a replicating vector based on Beet curly top virus in tobacco leaves and its immunogenicity in mice. Plant Cell Rep 8:1513–1521
12. Cummings JF, Guerrero ML, Moon JE, Waterman P, Nielsen RK, Jefferson S, Gross FL, Hancock K, Katz JM, Yusibov V (2014) Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a phase 1 dose-escalation study in healthy adults. Vaccine 32(19):2251–2259
13. da Hora VP, Conceição FR, Dellagostin OA, Doolan DL (2011) Non-toxic derivatives of LT as potent adjuvants. Vaccine 29:1538–1544
14. Donson J, Morris-Krsinich BAM, Mullineaux PM, Boulton MI, Davies JW (1984) A putative primer for second-strand DNA synthesis of maize streak virus is virion associated. EMBO J 3:3069–3073
15. Dougherty WG, Parks TD (1995) Transgenes and gene suppression: telling us something new? Current Opinion in Cell Biology 7:399–405
16. Dugdale B, Mortimer CL, Kato M, James TA, Harding RM, Dale JL (2013) In plant activation: an inducible, hyperexpression platform for recombinant protein production in plants. Plant Cell Online 25(7):2429–2443
17. Dugdale B, Mortimer CL, Kato M, James TA, Harding RM, Dale JL (2014) Design and construction of an in-plant activation cassette for transgene expression and recombinant protein production in plants. Nat Protoc 9(5):1010–1027
18. Fauquet CM, Briddon RW, Brown JK, Moriones E, Stanley J, Zerbini M, Zhou X (2008) Geminivirus strain demarcation and nomenclature. Arch Virol 153(4):783–821
19. Fernández-Fernández MR, Mouriflo M, Rivera J, Rodriguez F, Plana-Durán J, Garcia JA (2001) Protection of rabbits against rabbit hemorrhagic disease virus by immunization with the VP60 protein expressed in plants with a potyvirus-based vector. Virology 280:283–291
20. Fernández-Fernández MR, Martínez-Torrecuadrada JL, Roncal F, Domínguez E, García JA (2002) Identification of immunogenic hot spots within plum pox potyvirus capsid protein for efficient antigen presentation. J Virol 76(24):12646–12653
21. Foged C (2011) Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems. Ther Deliv 2:1057–1077
22. Gils M, Kandzia R, Marillonnet S, Klimyuk V, Gleba Y (2005) High-yield production of authentic human growth hormone using a plant virus-based expression system. Plant Biotechnol J 3:613–630
23. Gleba Y, Marillonnet S, Klimyuk V (2004) Engineering viral expression vectors for plants: the ‘full virus’ and the ‘deconstructed virus’ strategies. Curr Opin Plant Biol 7:182–188
24. Gleba Y, Klimyuk V, Marillonnet S (2005) Magnifection—a new platform for expressing recombinant vaccines in plants. Vaccine 23(17–18):2042–2048
25. Gleba Y, Klimyuk V, Marillonnet S (2007) Viral vectors for the expression of proteins in plants. Curr Opin Biotechnol 18:134–141
26. Gleba Y, Tusé D, Giritch A (2014) Plant viral vectors for delivery by Agrobacterium. In: Palmer K, Gleba Y (eds) Plant viral vectors. Springer, New York, pp 155–192
27. Gopinath K, Wellink J, Porta C, Taylor KM, Lomonossoff GP, van Kammen A (2000) Engineering cowpea mosaic virus RNA-2 into a vector to express heterologous proteins in plants. Virology 267:159–173
28. Greco R, Michel M, Guetard D, Cervantes-Gonzalez M, Pelucchi N, Wain-Hobson S, Sala F, Sala M (2007) Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine. Vaccine 25(49):8228–8240
29. Guo HS, López-Moya JJ, García JA (1998) Susceptibility to recombination rearrangements of a chimeric plum pox potyvirus genome after insertion of a foreign gene. Virus Res 57(2):183–195
30. Gutierrez C, Ramirez-Parra E, Mar Castellano M, Sanz-Burgos AP, Luque A, Missich R (2004) Geminivirus DNA replication and cell cycle interactions. Vet Microbiol 98:111–119
31. Haikonen T, Rajamäki ML, Tian YP, Valkonen JPT (2013) Mutation of a short variable region in HC-Pro protein of Potato virus A affects interactions with microtubule-associated protein and induces necrotic responses in tobacco. Mol Plant Microbe Interact 26:721–733
32. Hanley-Bowdoin L, Elmer JS, Rogers SG (1988) Transient expression of heterologous RNAs using tomato golden mosaic virus. Nucleic Acids Res 16(22):10511–10528
33. Hanley-Bowdoin L, Settlage SB, Orozco BM, Nagar S, Robertson D (1999) Geminiviruses: models for plant DNA replication, transcription, and cell cycle regulation. Crit Rev Plant Sci 18(1):71–106
34. Hanley-Bowdoin L, Bejarano ER, Robertson D, Mansoor S (2013) Geminiviruses: masters at redirecting and reprogramming plant processes. Nat Rev Microbiol 11(11):777–788
35. Haq TA, Mason HS, Clements JD, Arntzen CJ (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268:714–716
36. Hayes RJ, MacDonald H, Coutts RHA, Buck KW (1988a) Priming of complementary DNA synthesis in vitro by small DNA molecules tightly bound to virion DNA of wheat dwarf virus. J Gen Virol 69:1345–1350
37. Hayes RJ, Petty ITD, Coutts RH, Buck KW (1988b) Gene amplification and expression in plants by a replicating geminivirus vector. Nature 334:179–182
38. He J, Peng L, Lai H, Hurtado J, Stahnke J, Chen Q (2014) A plant-produced antigen elicits potent immune responses against West Nile virus in mice. Biomed Res Int 2014:952865
39. Hefferon KL (2012) Plant virus expression vectors set the stage as production platforms for bio pharmaceutical proteins. Virology 433(1):1–6
40. Hefferon KL, Fan Y (2004) Expression of a vaccine protein in a plant cell line using a geminivirus-based replicon system. Vaccine 23(3):404–410
41. Hernández M, Rosas G, Cervantes J, Fragoso G, Rosales-Mendoza S, Sciutto E (2014) Transgenic plants: a 5-year update on oral antipathogen vaccine development. Expert Rev Vaccines 27:1–14
42. Huang Z, Elkin G, Maloney BJ, Beuhner N, Arntzen CJ, Thanavala Y, Mason HS (2005) Virus-like particle expression and assembly in plants: hepatitis B and norwalk viruses. Vaccine 23(15):1851–1858
43. Huang Z, Le Pore K, Elkin G, Thanavala Y, Mason HS (2008) High-yield rapid production of hepatitis B surface antigen in plant leaf by a viral expression system. Plant Biotechnol J 6:202–209
44. Huang Z, Chen Q, Hjelm B, Arntzen C, Mason H (2009) A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnol Bioeng 103(4):706–714
45. Huang Z, Phoolcharoen W, Lai H, Piensook K, Cardineau G, Zeitlin L et al (2010) High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Biotechnol Bioeng 106(1):9–17
46. Kim SH, Jang YS (2014) Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Exp Mol Med 46:e85
47. Kim KI, Sunter G, Bisaro DM, Chung IS (2007) Improved expression of recombinant GFP using a replicating vector based on beet curly top virus in leaf-disks and infiltrated Nicotiana benthamiana leaves. Plant Mol Biol 64(1–2):103–112
48. Kim SH, Jung DI, Yang IY, Jang SH, Kim J, Truong TT et al (2013) Application of an M-cell-targeting ligand for oral vaccination induces efficient systemic and mucosal immune responses against a viral antigen. Int Immunol 25(11):623–632
49. Kumagai I (1993) Display of foreign protein on a coat protein of filamentous phage–phage antibody. Seikagaku 65(12):1509–1512
50. Kwon KC, Verma D, Singh ND, Herzog R, Daniell H (2013) Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv Drug Deliv Rev 65:782–799
51. Lai H, He J, Engle M, Diamond MS, Chen Q (2012) Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce. Plant Biotechnol J 10(1):95–104
52. Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, Vézina LP (2010) Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS ONE 5(12):e15559. doi:10.1371/journal.pone.0015559
53. Langridge W, Dénes B, Fodor I (2010) Cholera toxin B subunit modulation of mucosal vaccines for infectious and autoimmune diseases. Curr Opin Investig Drugs 11:919–928
54. Laufs J, Jupin I, David C, Schumacher S, Heyraud-Nitschke F, Gronenborn B (1995a) Geminivirus replication: genetic and biochemical characterization of Rep protein function, a review. Biochimie 77(10):765–773
55. Laufs J, Traut W, Heyraud F, Matzeit V, Rogers SG, Schell J, Gronenborn B (1995b) In vitro cleavage and joining at the viral origin of replication by the replication initiator protein of tomato yellow leaf curl virus. Proc Natl Acad Sci 92(9):3879–3883
56. Lazarowitz SG, WuL C, Rogers SG, Elmer JS (1992) Sequence-specific interaction with the viral AL1 protein identifies a geminivirus DNA replication origin. Plant Cell Online 4:799–809
57. Lindbo JA (2007) TRBO: a high-efficiency tobacco mosaic virus RNA-based overexpression vector. Plant Physiol 145(4):1232–1240
58. Liu L, Grainger J, Canizares MC, Angell SM, Lomonossoff GP (2004) Cowpea mosaic virus RNA-1 acts as an amplicon whose effects can be counteracted by a RNA-2-encoded suppressor of silencing. Virology 323:37–48
59. Lomonossoff GP, Hamilton WD (1999) Cowpea mosaic virus-based vaccines. Curr Top Microbiol Immunol 240:177–189
60. Ludwig C, Wagner R (2007) Virus-like particles-universal molecular toolboxes. Curr Opin Biol Technol 18(6):537–545
61. Marillonnet S, Thoeringer C, Kandzia R, Klimyuk V, Gleba Y (2005) Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat Biotech 23:718–723
62. Marusic C, Rizza P, Lattanzi L, Mancini C, Spada M, Belardelli F, Benvenuto E, Capone I (2001) Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1. J Virol 75(18):8434–8439
63. Mason HS, Herbst-Kralovetz MM (2012) Plant-derived antigens as mucosal vaccines. Curr Top Microbiol Immunol 354:101–120
64. Mason HS, Lam DM, Arntzen CJ (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA 89(24):11745–11749
65. Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK, Arntzen CJ (1996) Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci USA 93(11):5335–5340
66. Massa S, Franconi R, Brandi R, Muller A, Mett V et al (2007) Anti-cancer activity of plant-produced HPV16 E7 vaccine. Vaccine 25:3018–3021
67. Matić S, Rinaldi R, Masenga V, Noris E (2011) Efficient production of chimeric human papilloma virus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants. BMC Biotechnol 11:106. doi:10.1186/1472-6750-11-106
68. Matić S, Masenga V, Poli A, Rinaldi R, Milne RG, Vecchiati M, Noris E (2012) Comparative analysis of recombinant human papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods. Plant Biotechnol J 10(4):410–421
69. Matzeit V, Schaefer S, Kammann M, Schalk HJ, Schell J, Gronenborn B (1991) Wheat dwarf virus vectors replicate and express foreign genes in cells of monocotyledonous plants. Plant Cell Online 3(3):247–258
70. McLain L, Porta C, Lomonossoff GP, Durrani Z, Dimmock NJ (1995) Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus. AIDS Res Hum Retrovir 11(3):327–334
71. Mett V, Musiychuk K, Bi H, Farrance CE, Horsey A et al (2008) A plant produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respir Viruses 2:33–40
72. Meyer P, Heidmann I, Niedenhof I (1992) The use of African cassava mosaic virus as a vector system for plants. Gene 110(2):213–217
73. Meyers A, Chakauya E, Shephard E, Tanzer FL, Maclean J, Lynch A, Williamson AL, Rybicki EP (2008) Expression of HIV-1 antigens in plants as potential subunit vaccines. BMC Biotechnol 8:53. doi:10.1186/1472-6750-8-53
74. Mor TS, Moon YS, Palmer KE, Mason HS (2003) Geminivirus vectors for high-level expression of foreign proteins in plant cells. Biotechnol Bioeng 81(4):430–437
75. Moyle PM, Toth I (2013) Modern subunit vaccines: development, components, and research opportunities. Chem Med Chem 8:360–376
76. Musiychuk K, Stephenson N, Bi H, Farrance CE, Orozovic G et al (2007) A launch vector for the production of vaccine antigens in plants. Influenza Other Respir Viruses 1:19–25
77. Noris E, Poli A, Cojoca R, Rittà M, Cavallo F et al (2011) A human papillomavirus 8 E7 protein produced in plants is able to trigger the mouse immune system and delay the development of skin lesions. Arch Virol 156:587–595
78. Ohtake S, Arakawa T (2013) Recombinant therapeutic protein vaccines. Protein Pept Lett 20:1324–1344
79. Palmer KE, Thomson JA, Rybicki EP (1999) Generation of maize cell lines containing autonomously replicating maize streak virus-based gene vectors. Arch Virol 144(7):1345–1360
80. Pérez Filgueira DM, Zamorano PI, Domínguez MG, Taboga O, Del Médico Zajac MP, Puntel M, Romera SA, Morris TJ, Borca MV, Sadir AM (2003) Bovine herpes virus gD protein produced in plants using a recombinant Tobacco mosaic virus (TMV) vector possesses authentic antigenicity. Vaccine 21(27–30):4201–4209
81. Peterson RK, Arntzen CJ (2004) On risk and plant-based biopharmaceuticals. Trends Biotechnol 22(2):64–66
82. Pniewski T (2012) Is an oral plant-based vaccine against hepatitis B virus possible? Curr Pharm Biotechnol 13(15):2692–2704
83. Ravin NV, Kotlyarov RY, Mardanova ES, Kuprianov VV, Migunov AI, Stepanova LA, Tsybalova LM, Kiselev OI, Skryabin KG (2012) Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein. Biochemistry (Mosc) 77(1):33–40
84. Regnard GL, Halley-Stott RP, Tanzer FL, Hitzeroth II, Rybicki EP (2010) High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector. Plant Biotechnol J 8(1):38–46
85. Reinhart BJ, Weinstein EG, Rhoades MW, Bartel B, Bartel DP (2002) MicroRNAs in plants. Genes Dev 16:1616–1626
86. Rosales-Mendoza S, Salazar-González JA (2014) Immunological aspects of using plant cells as delivery vehicles for oral vaccines. Expert Rev Vaccines 13:737–749
87. Roy G, Weisburg S, Foy K, Rabindran S, Mett V, Yusibov V (2011) Co-expression of multiple target proteins in plants from a Tobacco mosaic virus vector using a combination of homologous and heterologous subgenomic promoters. Arch Virol 156(11):2057–2061
88. Saejung W, Fujiyama K, Takasaki T, Ito M, Hori K, Malasit P, Watanabe Y, Kurane I, Seki T (2007) Production of dengue 2 envelope domain III in plant using TMV-based vector system. Vaccine 25(36):6646–6654
89. Sainsbury F, Lavoie PO, D’Aoust MA, Vézina LP, Lomonossoff GP (2008) Expression of multiple proteins using full-length and deleted versions of Cowpea mosaic virus RNA-2. Plant Biotechnol J 6:82–92
90. Sainsbury F, Liu L, Lomonossoff GP (2009) Cowpea mosaic virus-based systems for the expression of antigens and antibodies in plants. Methods Mol Biol 483:25–39
91. Santa Cruz S, Chapman S, Roberts AG, Roberts IM, Prior DAM, Oparka KJ (1996) Assembly and movement of a plant virus carrying a green fluorescent protein overcoat. Proc Natl Acad Sci U S A 93:6286–6290
92. Santi L, Huang Z, Mason H (2006a) Virus-like particles production in green plants. Methods 40(1):66–76
93. Santi L, Giritch A, Roy CJ, Marillonnet S, Klimyuk V et al (2006b) Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proc Natl Acad Sci USA 103:861–866
94. Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J et al (2008) An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 26:1846–1854
95. Scholthof HB (2006) The Tombusvirus-encoded P19: from irrelevance to elegance. Nat Rev Microbiol 4:405–411
96. Shamloul M, Trusa J, Mett V, Yusibov V (2014) Optimization and utilization of Agrobacterium-mediated transient protein production in Nicotiana. J Vis Exp 86:51204
97. Shen WH, Hohn B (1994) Amplification and expression of the β-glucuronidase gene in maize plants by vectors based on maize streak virus. Plant J 5(2):227–236
98. Shen WH, Hohn B (1995) Vectors based on maize streak virus can replicate to high copy numbers in maize plants. J Gen Virol 76(4):965–969
99. Shima H, Watanabe T, Fukuda S, Fukuoka SI, Ohara O, Ohno H (2014) A novel mucosal vaccine targeting Peyer’s patch M cells induces protective antigen-specific IgA responses. Int Immunol 26:619–625
100. Shoji Y, Farrance CE, Bautista J, Bi H, Musiychuk K, Horsey A, Park H, Jaje J, Green BJ, Shamloul M, Sharma S, Chichester JA, Mett V, Yusibov V (2011) A plant-based system for rapid production of influenza vaccine antigens. Influenza Other Respir Viruses 6(3):204–210
101. Sijen T, Wellink J, Hiriart J-B, van Kammen A (1996) RNA-mediated virus resistance: role of repeated transgenes and delineation of targeted regions. Plant Cell 8:2277–2294
102. Tacket CO (2009) Plant-based oral vaccines: results of human trials. Curr Top Microbiol Immunol 332:103–117
103. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ (2000) Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 182(1):302–305
104. Thanavala Y, Yang YF, Lyons P, Mason HS, Arntzen C (1995) Immunogenicity of transgenic plant derived hepatitis B surface antigen. Proc Natl Acad Sci U S A 92(8):3358–3361
105. Toth RL, Chapman S, Carr F, Santa Cruz S (2001) A novel strategy for the expression of foreign genes from plant virus vectors. FEBS Lett 489(2–3):215–219
106. Turpen TH, Reinl SJ, Charoenvit Y, Hoffman SL, Fallarme V, Grill LK (1995) Malarial epitopes expressed on the surface of recombinant Tobacco mosaic virus. Biotechnology (NY) 13(1):53–57
107. Uhde K, Fischer R, Commandeur U (2005) Expression of multiple foreign epitopes presented as synthetic antigens on the surface of Potato virus X particles. Arch Virol 150(2):327–340
108. Voinnet O, Pinto YM, Baulcombe DC (1999) Suppression of gene silencing: a general strategy used by diverse DNA and RNA viruses. Proc Natl Acad Sci USA 96:14147–14152
109. Voinnet O, Rivas S, Mestre P, Baulcombe DC (2003) An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus. Plant J 33:949–956
110. Wagner B, Fuchs H, Adhami F, Ma Y, Scheiner O et al (2004) Plant virus expression systems for transient production of recombinant allergens in Nicotiana benthamiana. Methods 32:227–234
111. Ward A, Etessami P, Stanley J (1988) Expression of a bacterial gene in plants mediated by infectious geminivirus DNA. EMBO J 7(6):1583
112. Webster DE, Wang L, Mulcair M, Ma C, Santi L et al (2009) Production and characterization of an orally immunogenic plasmodium antigen in plants using a virus-based expression system. Plant Biotechnol J 7:846–855
113. Werner S, Breus O, Symonenko Y, Marillonnet S, Gleba Y (2011) High-level recombinant protein expression in transgenic plants by using a double-inducible viral vector. Proc Natl Acad Sci USA 108:14061–14066
114. Wigdorovitz A, Pérez Filgueira DM, Robertson N, Carrillo C, Sadir AM, Morris TJ, Borca MV (1999) Protection of mice against challenge with Foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant Tobacco mosaic virus expressing the FMDV structural protein VP1. Virology 264(1):85–91
115. Ye T, Yue Y, Fan X, Dong C, Xu W, Xiong S (2014) M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine. Vaccine 32:4457–4465
116. Yusibov V, Mett V, Mett V, Davidson C, Musiychuk K, Gilliam S, Farese A, Macvittie T, Mann D (2005) Peptide-based candidate vaccine against Respiratory syncytial virus. Vaccine 23(17–18):2261–2265
117. Yusibov V, Streatfield SJ, Kushnir N (2011) Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum Vaccin 7(3):313–321
118. Zhang X, Mason H (2006) Bean Yellow Dwarf Virus replicons for high-level transgene expression in transgenic plants and cell cultures. Biotechnol Bioeng 93:271–279